Pujals S, Sabidó E, Tarragó T, Giralt E
Institute for Research in Biomedicine (IRB), Barcelona Science Park, Josep Samitier 1-5, 08028 Barcelona, Spain.
Biochem Soc Trans. 2007 Aug;35(Pt 4):794-6. doi: 10.1042/BST0350794.
Proline-rich cell-penetrating peptides, particularly the SAP (sweet arrow peptide), (VRLPPP)(3), have been proposed to be useful intracellular delivery vectors, as a result of their lack of cytotoxicity combined with their capacity to be internalized by cells. A common limitation of the therapeutic use of peptides is metabolic instability. In general, peptides are quickly degraded by proteases upon entry into the bloodstream. The use of all-D-peptide derivatives is emerging as a fruitful strategy to circumvent this degradation problem. In this context, we report on the internalization behaviour, protease-resistance enhancement and self-assembly properties of an all-D version of SAP [(vrlppp)(3)]. The cellular uptake of (vrlppp)(3) was evaluated in an in vivo assay in mice. Both flow cytometry and confocal laser-scanning microscopy experiments showed that a carboxyfluoresceinated version of the molecule, carboxyfluorescein-(vrlppp)(3), is internalized rapidly in white blood cells and kidney cells. Significant fluorescence was also detected in other organs such as the spleen and the liver. Finally, the toxicity of (vrlppp)(3) was examined, and no significant differences in the main biochemical parameters nor in weight were detected compared with controls.
富含脯氨酸的细胞穿透肽,特别是SAP(甜箭肽),即(VRLPPP)(3),因其缺乏细胞毒性且具有被细胞内化的能力,已被认为是有用的细胞内递送载体。肽类治疗应用的一个常见限制是代谢不稳定性。一般来说,肽进入血液后会迅速被蛋白酶降解。使用全D-肽衍生物正成为一种有效的策略来规避这种降解问题。在此背景下,我们报告了全D版SAP [(vrlppp)(3)]的内化行为、蛋白酶抗性增强和自组装特性。在小鼠体内试验中评估了(vrlppp)(3)的细胞摄取。流式细胞术和共聚焦激光扫描显微镜实验均表明,该分子的羧基荧光素化版本,即羧基荧光素-(vrlppp)(3),能在白细胞和肾细胞中迅速内化。在脾脏和肝脏等其他器官中也检测到了显著荧光。最后,检测了(vrlppp)(3)的毒性,与对照组相比,主要生化参数和体重均未检测到显著差异。